volulyte 6% solution for infusion
fresenius kabi limited - poly(o-2-hydroxyethyl)starch; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium chloride - solution for infusion - poly(o-2-hydroxyethyl)starch 60 g; potassium chloride 0.3 g; magnesium chloride hexahydrate 0.3 g; sodium acetate trihydrate 4.63 g; sodium chloride 6.02 g - blood substitutes and perfusion solutions
lumicain- aluminium chloride hexahydrate solution
medical products laboratories, inc. - aluminum chloride (unii: 3cyt62d3ga) (aluminum cation - unii:3xhb1d032b) -
keratex khh- aluminium chloride, glycerin, formaldehyde, alcohol and methyl alcohol liquid
penleigh irving ltd - aluminum chloride (unii: 3cyt62d3ga) (aluminum cation - unii:3xhb1d032b), glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), formaldehyde (unii: 1hg84l3525) (formaldehyde - unii:1hg84l3525), alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m), methyl alcohol (unii: y4s76jwi15) (methyl alcohol - unii:y4s76jwi15) - aluminum chloride 0.408 g in 1.675 ml
aminoven 3.5 per cent solution for infusion
fresenius kabi limited - tyrosine, isoleucine, leucine, lysine hydrochloride, methionine, active, phenylalanine, threonine, tryptophan, l-, valine, arginine, histidine, alanine, aminoacetic acid, proline, serine, taurine, glucose monohydrate, sodium chloride, calcium chloride dihydrate, magnesium chloride hexahydrate, zinc chloride - solution for infusion - 3.5 per cent - solutions for parenteral nutrition
southphos aluminium phosphide tablets
envirofume limited - aluminium phosphide - aluminium phosphide 570 g/kg - insecticide
brineura cerliponase alfa (rch) 150 mg/5 ml solution for injection vial with flushing solution vial
biomarin pharmaceutical australia pty ltd - cerliponase alfa, quantity: 30 mg/ml - injection, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; sodium chloride; potassium chloride; magnesium chloride hexahydrate; calcium chloride dihydrate; water for injections; monobasic sodium phosphate monohydrate - brineura is indicated for the treatment of neuronal ceroid lipofuscinosis type 2 (cln2) disease, also known as tripeptidyl peptidase 1 (tpp1) deficiency.
anhydrol forte 20%
imed healthcare ltd. - aluminium chloride hexahydrate - not currently available - 20 percent
drysol topical solution
momtaz pharmaceuticals ltd. - aluminium chloride hexahydrate - topical solution - 20 gm/100 ml
apirent topical solution
opsonin pharma limited - aluminium chloride hexahydrate - topical solution - 20 gm/100 ml
sudor-x topical solution
unimed unihealth pharmaceuticals ltd. - aluminium chloride hexahydrate - topical solution - 20 gm/100 ml